drugset / Trial / NCT02523651

Periodontal Regeneration of Chronic Periodontal Disease Patients Receiving Stem Cells Injection Therapy

NCT02523651 ↗

Phase 1/2 Unknown 40 enrolled Songlin Wang
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety of clinical injection of allogeneic human dental pulp stem cell(DPSC) in local infected periodontal tissue and determine whether injection of allogeneic DPSC is a effective way in the treatment of chronic periodontal disease.

Timeline

Start
2014-12
Primary completion
2015-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject DPSC Cell therapy 1e+06 cells Other

Indications